Read more about the article MaxCyte Enters Strategic License Agreement with TG Therapeutics for Cell-Based Therapy Development
MaxCyte Enters Strategic License Agreement with TG Therapeutics for Cell-Based Therapy Development

MaxCyte Enters Strategic License Agreement with TG Therapeutics for Cell-Based Therapy Development

MaxCyte enters a strategic licensing agreement with TG Therapeutics for Flow Electroporation® technology to advance cell-based therapies.Quiver AI SummaryMaxCyte, Inc. announced a strategic platform license agreement with TG Therapeutics, a…

Continue ReadingMaxCyte Enters Strategic License Agreement with TG Therapeutics for Cell-Based Therapy Development
Read more about the article FTI Consulting Welcomes Christoph Söhngen and Sebastian Rudow as Senior Managing Directors to Enhance Corporate Finance & Restructuring Capabilities in Frankfurt
FTI Consulting Welcomes Christoph Söhngen and Sebastian Rudow as Senior Managing Directors to Enhance Corporate Finance & Restructuring Capabilities in Frankfurt

FTI Consulting Welcomes Christoph Söhngen and Sebastian Rudow as Senior Managing Directors to Enhance Corporate Finance & Restructuring Capabilities in Frankfurt

FTI Consulting enhances its Frankfurt team with Christoph Söhngen and Sebastian Rudow as Senior Managing Directors, strengthening corporate finance and restructuring expertise.Quiver AI SummaryFTI Consulting, Inc. has announced the appointment…

Continue ReadingFTI Consulting Welcomes Christoph Söhngen and Sebastian Rudow as Senior Managing Directors to Enhance Corporate Finance & Restructuring Capabilities in Frankfurt

End of content

No more pages to load